These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 10386529)
1. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529 [TBL] [Abstract][Full Text] [Related]
2. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
3. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Reunanen M; Dam M; Yuen AW Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276 [TBL] [Abstract][Full Text] [Related]
5. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Brodie MJ; Overstall PW; Giorgi L Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Brodie MJ; Yuen AW Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723 [TBL] [Abstract][Full Text] [Related]
7. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Saetre E; Perucca E; Isojärvi J; Gjerstad L; Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Fitton A; Goa KL Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554 [TBL] [Abstract][Full Text] [Related]
10. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study. Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM; J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069 [TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Gillham R; Kane K; Bryant-Comstock L; Brodie MJ Seizure; 2000 Sep; 9(6):375-9. PubMed ID: 10985991 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Brodie MJ; Richens A; Yuen AW Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545 [TBL] [Abstract][Full Text] [Related]
16. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401 [TBL] [Abstract][Full Text] [Related]
17. Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin. Anderson GD; Gidal BE; Messenheimer JA; Gilliam FG Epilepsy Res; 2002 May; 49(3):211-7. PubMed ID: 12076842 [TBL] [Abstract][Full Text] [Related]
18. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674 [TBL] [Abstract][Full Text] [Related]
19. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy]. Juryńczyk J; Weglewski A Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903 [TBL] [Abstract][Full Text] [Related]
20. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L; Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]